|
|
(more...)
, (less...)
Add to My Group(s)
Add to My Group(s)
By Evelyn Pringle (about the author)
Become a Fan -- Page 4 of 4 page(s)
The study determined that between 1997 and 2002, a total of 85 suspected Accutane related cases of IBD were reported. In four cases, Accutane was graded as the "highly probable" cause, by the researchers, while 58 cases were deemed a "probable" cause, and in 23 cases it was listed as a "possible" cause. None of the links between Accutane and IBD were graded in the category labeled "doubtful."
"Physicians and patients should be made aware of this possible association and it should be included in the already extensive consent process required before isotretinoin is prescribed," the researchers wrote in the journal.
Additional side effects associated with the drug were also revealed last month in a study that appeared in the August 21, 2006 Archives of Dermatology, conducted by researchers at the University of California, San Francisco, that found Accutane raises levels of cholesterol and triglyceride fats in the body.
The study reviewed the cases of 13,772 patients between the ages of 13 to 50, who were treated with Accutane between March 1995 and September 2002.
The results of the study showed that 31% of patients taking Accutane developed high cholesterol levels, 44% patients with previously normal levels developed high triglyceride levels, and 11% of the patients reported high liver transaminase (liver enzymes) levels.
To date, other serious side effects associated with Accutane include problems with the pancreas, liver, stomach, bones, muscles, hearing, vision, allergic reactions, blood sugar, or red and white blood cells. According to the iPLEDGE web site, the most common, less serious side effects include dry skin, chapped lips, dry eyes, and dry nose that may lead to nosebleeds.
The FDA needs to yank this drug off the market once and for all. Weighed against its endless list of serious side effects, there is no justifiable reason to keep it on the market. Let the drug companies develop a new drug to treat acne.
More information for injured parties can be found at Lawyers and Settlements.com
http://www.lawyersandsettlements.com/
Evelyn Pringle
evelyn.pringle@sbcglobal.net
(Evelyn Pringle is a columnist for OpEd News and an investigative journalist focused on exposing corruption in government and corporate America)
Become a Fan -- Page 4 of 4 page(s)
"Physicians and patients should be made aware of this possible association and it should be included in the already extensive consent process required before isotretinoin is prescribed," the researchers wrote in the journal.
Additional side effects associated with the drug were also revealed last month in a study that appeared in the August 21, 2006 Archives of Dermatology, conducted by researchers at the University of California, San Francisco, that found Accutane raises levels of cholesterol and triglyceride fats in the body.
The study reviewed the cases of 13,772 patients between the ages of 13 to 50, who were treated with Accutane between March 1995 and September 2002.
The results of the study showed that 31% of patients taking Accutane developed high cholesterol levels, 44% patients with previously normal levels developed high triglyceride levels, and 11% of the patients reported high liver transaminase (liver enzymes) levels.
To date, other serious side effects associated with Accutane include problems with the pancreas, liver, stomach, bones, muscles, hearing, vision, allergic reactions, blood sugar, or red and white blood cells. According to the iPLEDGE web site, the most common, less serious side effects include dry skin, chapped lips, dry eyes, and dry nose that may lead to nosebleeds.
The FDA needs to yank this drug off the market once and for all. Weighed against its endless list of serious side effects, there is no justifiable reason to keep it on the market. Let the drug companies develop a new drug to treat acne.
More information for injured parties can be found at Lawyers and Settlements.com
http://www.lawyersandsettlements.com/
Evelyn Pringle
evelyn.pringle@sbcglobal.net
(Evelyn Pringle is a columnist for OpEd News and an investigative journalist focused on exposing corruption in government and corporate America)
Evelyn Pringle is a columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America.
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.
 Contact Author |
Contact Editor |
 View Authors' Articles |
Comments
The time limit for entering new comments on this article has expired.
This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.
| No comments |